NEWSLETTER
Inside Shanghai and Seoul's Top Longevity Clinics
Field notes from two weeks touring longevity clinics and hospitals across China and South Korea - the opportunities, the challenges, and what it means for physicians building this field.
DL
Dr. David Luu uly 20, 2026 - 7 min read
Hey Doc,
I just got back from Shanghai and Seoul, and I am fired up. I visited clinics, hospitals, met dozens of physicians and owners, all building longevity care on opposite sides of the planet. The infrastructure is here, and it is going up fast.
Look at this week. Neko raised $700 million to put prevention within reach of everyone, not just the wealthy. Lilly became the first trillion-dollar drug company by betting on preventive medicine. A $13,500 robot performed live surgery with the physician in the loop the whole time.
Prevention is being democratized. The tools are getting cheaper, the reach is getting wider, and for the first time we can bring this to millions of patients, on every continent, not a lucky few.
That is our mission. The infrastructure is being built right now. Super grateful to be meeting the physicians building it around the world!
Dr. David Luu, Founder, longevitydocs.™
Each week, I try to explore one idea that could advance longevity medicine and hopefully support physicians in bringing it to life. For my full perspective read on and subscribe.
Field Notes from Shanghai and Seoul
What I Learned Visiting Clinics and Hospitals in China and South Korea
I just spent two weeks in Shanghai and Seoul, meeting physicians and leaders and walking through their clinics and hospitals. Here is my honest summary, the opportunities and the challenges:
Opportunities
-
Experience. Some of these clinics and hospitals are designed like five-star hotels. Impeccable amenities, real architecture, the finish of a luxury property. The space itself tells the patient this is serious.
-
Equipment and technology. Rooms full of the latest imaging, CT, MRI, DEXA, functional diagnostics, at a level most Western clinics would think twice before buying. Some cosmetic-focused clinics run twenty-plus devices worth several million dollars, the newest of everything, all under one roof.
-
Price. They can be strikingly competitive, a full workup for a few thousand dollars. And even when they reach Western prices, they deliver it in a few hours instead of spreading it across days.
-
Scale and speed. Care moves fast, sometimes finished in hours, and they handle large numbers of patients at once without the experience falling apart.
-
Longevity tourism. Put the price, the equipment, the experience, and the speed together and you have a destination, not just a clinic. Patients will travel for a week of diagnostics and a level of care they cannot get, or cannot afford, where they live. Asia is quietly positioning itself to be where they land.
Challenges
-
Regulation. Every country has its own rules, and in most of them nobody has defined what longevity medicine even is yet. That is freedom and risk in the same breath, because what is allowed today can close tomorrow and no one is building on ground they trust.
-
Language. It is a wall that works in two directions. A patient will not fly toward a place they cannot talk to, and the best training and literature still move in English, so both the patients and the knowledge travel slower than they should.
-
Communicating the care. Nobody has figured out how to explain this medicine simply, to patients or to referring physicians, what it does and why it is worth paying for. The value is real. The language for it is not built yet.
-
Patient acquisition and competition. Beautiful buildings, serious equipment, strong teams, and the hardest question in every room is still how to fill the schedule. The category is getting crowded fast, so differentiation stopped being optional, and nobody has actually solved acquisition.
-
No institutional framework. There is no shared standard, no common credential, no agreed definition of what a longevity clinic actually is. Everyone is building their own version.
-
Access to education. The hunger to learn was everywhere I went, and it genuinely moved me. But the training pipeline is narrow and expensive, demand far outruns supply, and it still needs to be adapted to local culture and regulation.
-
Recruiting doctors. You can buy the machines. You cannot buy the physician who knows how to read them, and everyone is chasing the same short list of people who can. The talent is the bottleneck, not the capital.
I came back genuinely impressed. What they are building in preventive, cosmetic, and dental care is real and moving fast, and longevity is firmly on the map. They will deliver.
And what I saw in Shanghai and Seoul is the same everywhere. This is not an Asia story, it is the shape of the field worldwide. Longevity care is becoming an economic asset, the way a country's hospitals and universities already are. The investment will build the infrastructure, the buildings, the machines, the scale, with or without us.
Capital builds the infrastructure. Trained physicians deliver the care, and that is what makes them the most valuable asset in the building. So if you run a clinic or a hospital, the highest-return investment you can make is not another scanner. It is training your doctors.
That is exactly what we are building at longevitydocs.™: the certification and the training program for the longevity physician of the future. Every doctor should be a longevity doctor.
About Dr. David Luu, MD™ Dr. David Luu, MD, is the Founder of longevitydocs™. He is a trained pediatric cardiac surgeon, longevity tech entrepreneur, and philanthropist who helps physicians, organizations, and leaders build the global infrastructure of longevity medicine. About longevitydocs™ longevitydocs™ is the world's leading longevity physician community. Over 1,200 doctors across 50+ countries united by a single conviction: every doctor should be a longevity doctor. We are building the infrastructure, education, and community physicians need to make longevity medicine their default practice.
Editorial Disclaimer
This newsletter is published exclusively for licensed physicians and qualified healthcare professionals. It is not intended for consumers or patients.
All content is for continuing medical education and professional information purposes only. It reflects emerging research, science, and technology that may have implications for the practice of medicine. It does not constitute medical advice, clinical recommendations, or treatment guidance for any individual patient.
By reading this newsletter, you confirm that you are a licensed healthcare professional and that you will apply the information contained herein within the bounds of your clinical judgment, professional obligations, and applicable regulations.
If you are a patient or consumer reading this newsletter, please note that this content should not be used to make any health or medical decisions. Please consult your personal physician or a qualified healthcare provider for guidance specific to your situation.
Inside Shanghai and Seoul's Top Longevity Clinics
Inside Shanghai and Seoul's Top Longevity Clinics
Field notes from two weeks touring longevity clinics and hospitals across China and South Korea - the opportunities, the challenges, and what it means for physicians building this field.
Hey Doc,
I just got back from Shanghai and Seoul, and I am fired up. I visited clinics, hospitals, met dozens of physicians and owners, all building longevity care on opposite sides of the planet. The infrastructure is here, and it is going up fast.
Look at this week. Neko raised $700 million to put prevention within reach of everyone, not just the wealthy. Lilly became the first trillion-dollar drug company by betting on preventive medicine. A $13,500 robot performed live surgery with the physician in the loop the whole time.
Prevention is being democratized. The tools are getting cheaper, the reach is getting wider, and for the first time we can bring this to millions of patients, on every continent, not a lucky few.
That is our mission. The infrastructure is being built right now. Super grateful to be meeting the physicians building it around the world!
Dr. David Luu, Founder, longevitydocs.™
Each week, I try to explore one idea that could advance longevity medicine and hopefully support physicians in bringing it to life. For my full perspective read on and subscribe.
Field Notes from Shanghai and Seoul
What I Learned Visiting Clinics and Hospitals in China and South Korea
I just spent two weeks in Shanghai and Seoul, meeting physicians and leaders and walking through their clinics and hospitals. Here is my honest summary, the opportunities and the challenges:
Opportunities
Experience. Some of these clinics and hospitals are designed like five-star hotels. Impeccable amenities, real architecture, the finish of a luxury property. The space itself tells the patient this is serious.
Equipment and technology. Rooms full of the latest imaging, CT, MRI, DEXA, functional diagnostics, at a level most Western clinics would think twice before buying. Some cosmetic-focused clinics run twenty-plus devices worth several million dollars, the newest of everything, all under one roof.
Price. They can be strikingly competitive, a full workup for a few thousand dollars. And even when they reach Western prices, they deliver it in a few hours instead of spreading it across days.
Scale and speed. Care moves fast, sometimes finished in hours, and they handle large numbers of patients at once without the experience falling apart.
Longevity tourism. Put the price, the equipment, the experience, and the speed together and you have a destination, not just a clinic. Patients will travel for a week of diagnostics and a level of care they cannot get, or cannot afford, where they live. Asia is quietly positioning itself to be where they land.
Challenges
Regulation. Every country has its own rules, and in most of them nobody has defined what longevity medicine even is yet. That is freedom and risk in the same breath, because what is allowed today can close tomorrow and no one is building on ground they trust.
Language. It is a wall that works in two directions. A patient will not fly toward a place they cannot talk to, and the best training and literature still move in English, so both the patients and the knowledge travel slower than they should.
Communicating the care. Nobody has figured out how to explain this medicine simply, to patients or to referring physicians, what it does and why it is worth paying for. The value is real. The language for it is not built yet.
Patient acquisition and competition. Beautiful buildings, serious equipment, strong teams, and the hardest question in every room is still how to fill the schedule. The category is getting crowded fast, so differentiation stopped being optional, and nobody has actually solved acquisition.
No institutional framework. There is no shared standard, no common credential, no agreed definition of what a longevity clinic actually is. Everyone is building their own version.
Access to education. The hunger to learn was everywhere I went, and it genuinely moved me. But the training pipeline is narrow and expensive, demand far outruns supply, and it still needs to be adapted to local culture and regulation.
Recruiting doctors. You can buy the machines. You cannot buy the physician who knows how to read them, and everyone is chasing the same short list of people who can. The talent is the bottleneck, not the capital.
I came back genuinely impressed. What they are building in preventive, cosmetic, and dental care is real and moving fast, and longevity is firmly on the map. They will deliver.
And what I saw in Shanghai and Seoul is the same everywhere. This is not an Asia story, it is the shape of the field worldwide. Longevity care is becoming an economic asset, the way a country's hospitals and universities already are. The investment will build the infrastructure, the buildings, the machines, the scale, with or without us.
Capital builds the infrastructure. Trained physicians deliver the care, and that is what makes them the most valuable asset in the building. So if you run a clinic or a hospital, the highest-return investment you can make is not another scanner. It is training your doctors.
That is exactly what we are building at longevitydocs.™: the certification and the training program for the longevity physician of the future. Every doctor should be a longevity doctor.
This newsletter is published exclusively for licensed physicians and qualified healthcare professionals. It is not intended for consumers or patients.
All content is for continuing medical education and professional information purposes only. It reflects emerging research, science, and technology that may have implications for the practice of medicine. It does not constitute medical advice, clinical recommendations, or treatment guidance for any individual patient.
By reading this newsletter, you confirm that you are a licensed healthcare professional and that you will apply the information contained herein within the bounds of your clinical judgment, professional obligations, and applicable regulations.
If you are a patient or consumer reading this newsletter, please note that this content should not be used to make any health or medical decisions. Please consult your personal physician or a qualified healthcare provider for guidance specific to your situation.